0.281

0.04% 0.0001

After Hours: .29 0.009 +3.20%

IGC Pharma Inc (IGC)

Overview News Price History Option Chain Discussions Forecast Stock Split

IGC Pharma Inc stock is traded at $0.281, with a volume of 337.96K. It is up +0.04% in the last 24 hours and down -1.75% over the past month. India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.

Previous Close:

$0.2809

Open:

$0.2841

24h Volume:

337.96K

Relative Volume:

0.29

Market Cap:

$28.13M

Revenue:

$1.27M

Net Income/Loss:

$-7.12M

P/E Ratio:

-5.3831

EPS:

-0.0522

Net Cash Flow:

$-5.28M

1W Performance:

+3.69%

1M Performance:

-1.75%

6M Performance:

-2.77%

1Y Performance:

-7.11%

1-Day Range:

$0.269

$0.2941

1-Week Range:

$0.269

$0.2941

52-Week Range:

$0.242

$0.4985

IGC Pharma Inc Stock (IGC) Company Profile

Name

IGC Pharma Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

301-983-0998

Address

4336 Montgomery Avenue, Bethesda, MD

Employee

Twitter

@IGCIR

Next Earnings Date

2026-08-13

Latest SEC Filings

IGC's Discussions on Twitter

Compare IGC vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IGC IGC Pharma Inc	0.281	27.22M	1.27M	-7.12M	-5.28M	-0.0522
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

IGC Pharma Inc Stock (IGC) Latest News

Jul 01, 2026

IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares - openPR.com

Jul 01, 2026

Form 4 IGC Pharma Inc For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026

IGC Pharma (IGC) CEO converts $601K company debt into 2.23M shares - Stock Titan

Jul 01, 2026

Debt-for-equity swap gives IGC Pharma (IGC) PFO 2.0M new shares - Stock Titan

Jul 01, 2026

Jun 30, 2026

Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates - openPR.com

Jun 30, 2026

MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now - openPR.com

Jun 30, 2026

Jun 26, 2026

Enterprise value to revenue forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView

Jun 26, 2026

Enterprise value to EBITDA forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView

Jun 25, 2026

IGC Pharma, Inc. Actuals & Estimates (DUS:IGS1) - TradingView

Jun 25, 2026

Enterprise value to EBIT forward of IGC Pharma, Inc. – AMEX:IGC - TradingView

Jun 25, 2026

IGC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Price to sales forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView

Jun 25, 2026

Enterprise value to EBIT forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView

Jun 25, 2026

Jun 24, 2026

IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug Discovery - Barchart.com

Jun 24, 2026